Press
Keep up with the latest news and press releases from the Summit.
Media Information 2021
Media Collaboration with the news magazine BIOTECH FINANCES
Â
Philadelphia Business Journal
Press Release 2019
3rd edition of the Boston Biotechnology Summit™:
A Bridge for Collaboration
Cambridge MA, 30 May 2019 – The 3rd Boston Biotechnology Summit will be held on Sunday, 2 June 2019 at the renowned Wistar Institute in Philadelphia (USA), just before the BIO 2019 Convention. The central theme of this third edition will be collaboration, common foundations, research project development, obtaining regulatory approval and the marketing of products from the biotechnology industry.
Pravin Chaturvedi, PhD, 2019 Guest Program Chair, (together with Shahin Gharakhanian, MD, Co-Founder & International Program Committee Chair), who declares: “The biotechnology industry faces both opportunities and challenges in terms of technology and finance. Our success will always depend on the quality of collaborative efforts. For this reason, as Guest Program Chair, I believe in the importance of in-depth debate on this central theme at the Boston Biotechnology Summit on June 2 in Philadelphia. We are therefore inviting our colleagues to attend and participate fully in these discussions”.
Highlights of the Summit:
Biotech companies and pharmaceutical groups: Acticor, Alkermes, Bayer USA, GSK/ViiV Healthcare, Johnson & Johnson, Merck, Nanobiotix, etc.
Investors and financial platforms: AWEX, FEP Capital Advisors, Gurnet Point Capital, ($2 billion investment fund), Launchpad Ventures LLC, LSN: Life Science Nation, Nowak Ventures LLC, and groups with operations in Asia, the US and EU.
Press Release 15 May 2019
3ème édition du Boston Biotechnology Summit™ :
Un Pont pour la Collaboration
Paris (France), le 15 Mai 2019 – le « 3rd Boston Biotechnology Summit™ » se tiendra le dimanche 2 Juin 2019 au cĂ©lèbre Wistar Institute Ă Philadelphie (Etats-Unis), juste avant la Convention BIO 2019.
La thématique centrale de cette troisième édition sera la collaboration, socle commun, des projets de recherche développement, d’approbation règlementaire et mise sur le marché de produits issus de l’industrie des biotechnologies.
Le Dr. Shahin Gharakhanian, spécialiste de Développement Clinique et de Médecine Pharmaceutique, co-fondateur et Président du Comité de Programmation annonce : « Après les réussites du 1er Sommet de Biotechnologie Boston/Paris à l’Institut Pasteur en 2017, et la seconde édition en 2018 à l’Exchange Conference Center, lieu historique, à Boston, nous avons franchi cette année une étape stratégique par le choix et l’implication des orateurs américains et européens, mais aussi par la présence grandissante d’investisseurs asiatiques. Plus que jamais, cet événement vient compléter parfaitement l’agenda des acteurs français inscrits à BIO2019 »
Parmi les orateurs-experts présents à cette 3ème édition :
- Sociétés de biotechnologies et groupes pharmaceutiques : Acticor, Alkermes, Bayer USA, GSK/ViiV Healthcare, Johnson & Johnson, Merck, Nanobiotix …
- Investisseurs et plateformes financières : AWEX, FEP Captal Advisors, Gurnet Point Capital, (fond d’investissement de $2 Milliards), Launchpad Ventures LLC, LSN, Life Science Nation ainsi que des groupes ayant des opérations à Pékin, Shanghai, Bruxelles, Boston, Philadelphie et New York.
- Institutions et Universitaires : Business France, « Forum for Collaborative Research » France Biotech, « German Accelerator Life Sciences Program », Genopole, Initiative pour les Médicaments Innovants (IMI) en Europe, The Wistar Institute, « Massachusetts Biotechnology Council », Universités d’Aix/Marseille, GSU College of Public Health, Montréal, LMU Munich.
- Dix jeunes sociĂ©tĂ©s de biotechnologies, des « start-ups » sĂ©lectionnĂ©es, viendront prĂ©senter leur projet Ă un panel d’experts thĂ©rapeutiques et rĂ©glementaires, investisseurs, et industriels pharmaceutiques. Trois sociĂ©tĂ©s françaises de Lille, Paris et Marseille en font partie.Â
Headlines Biotech Finances Journal
Front page, no. 813, May 2018
Press Release 30 May, 2018
Boston-Paris Biotechnology Summit®
Boston-Paris Biotechnology Summit®: Bringing Together Leaders to Bridge Business Partnerships. A Day of Learning and Meeting on New Sources of Financing and Strategic Partnerships.Â
Boston, Massachusetts – 30 May, 2018 -The BOSTON-PARIS Biotechnology Summit®, an international conference that aims to foster innovation and partnerships between key trans-Atlantic stakeholders, will be hosting its second annual meeting at the Boston Exchange Center on June 3, 2018. The Summit will feature thought-leaders from biotechnology, pharmaceutical companies, city and regional bio-clusters, alongside institutional, philanthropic and strategic investors.
Press Release – March 29, 2017
BOSTON-PARIS Biotechnology Summit ® 1st Edition of the First Franco-American Exchange Event, May 18, 2017 at the Pasteur Institute, Paris 75015.
March 29, 2017: Â The BOSTON-PARIS Biotechnology Summit, an international exchange conference bringing together key players from Boston and France in the biotech and investment industry, announces that it will hold its first edition in Paris on May 18, 2017, in the historic Amphitheater Duclaux of the Pasteur Institute.
Communiqué de Presse – 29 Mars 2017
Paris, France – March 29, 2017 -The BOSTON-PARIS Biotechnology Summit, an international trade conference bringing together the major Boston and French-speaking players in the biotech investment industry, is announcing that it will hold its first edition in Paris on May 18, 2017, at the Pasteur Institute’s historic Duclaux Amphitheatre.
2017 Press Coverage
- Boursorama, Paris, Issue # 23 May 2017
- La Bourse et La Vie, Paris, Issue # 19 April 2017
Interview with Shahin Gharakhanian,
- Les ECHOS, Circa 2Q2017.
- La Revenue Française, Internet Broadcast # 19 April 2017
Interview with Shahin Gharakhanian.
